Nucleic acid binding, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 25 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A0A3Q8IRM8
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 9 |
GO:0003723 | RNA binding | 4 | 9 |
GO:0005488 | binding | 1 | 9 |
GO:0097159 | organic cyclic compound binding | 2 | 9 |
GO:1901363 | heterocyclic compound binding | 2 | 9 |
GO:0003729 | mRNA binding | 5 | 1 |
GO:0003730 | mRNA 3'-UTR binding | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 132 | 138 | PF00089 | 0.264 |
CLV_NRD_NRD_1 | 111 | 113 | PF00675 | 0.468 |
CLV_PCSK_KEX2_1 | 182 | 184 | PF00082 | 0.289 |
CLV_PCSK_PC1ET2_1 | 182 | 184 | PF00082 | 0.289 |
CLV_PCSK_SKI1_1 | 143 | 147 | PF00082 | 0.331 |
CLV_PCSK_SKI1_1 | 182 | 186 | PF00082 | 0.264 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.625 |
DOC_MAPK_FxFP_2 | 161 | 164 | PF00069 | 0.531 |
DOC_MAPK_gen_1 | 110 | 117 | PF00069 | 0.410 |
DOC_MAPK_gen_1 | 95 | 104 | PF00069 | 0.676 |
DOC_PP1_RVXF_1 | 141 | 147 | PF00149 | 0.531 |
DOC_PP4_FxxP_1 | 161 | 164 | PF00568 | 0.489 |
DOC_USP7_MATH_1 | 103 | 107 | PF00917 | 0.547 |
DOC_USP7_MATH_1 | 26 | 30 | PF00917 | 0.609 |
DOC_WW_Pin1_4 | 28 | 33 | PF00397 | 0.629 |
DOC_WW_Pin1_4 | 85 | 90 | PF00397 | 0.691 |
LIG_14-3-3_CanoR_1 | 148 | 153 | PF00244 | 0.531 |
LIG_14-3-3_CanoR_1 | 95 | 105 | PF00244 | 0.680 |
LIG_FHA_1 | 188 | 194 | PF00498 | 0.490 |
LIG_FHA_1 | 97 | 103 | PF00498 | 0.623 |
LIG_FHA_2 | 123 | 129 | PF00498 | 0.481 |
LIG_FHA_2 | 72 | 78 | PF00498 | 0.653 |
LIG_LIR_Gen_1 | 131 | 139 | PF02991 | 0.464 |
LIG_LIR_Nem_3 | 131 | 136 | PF02991 | 0.464 |
LIG_MYND_1 | 52 | 56 | PF01753 | 0.648 |
LIG_SH2_CRK | 156 | 160 | PF00017 | 0.464 |
LIG_SH2_STAT3 | 111 | 114 | PF00017 | 0.415 |
LIG_SH2_STAT3 | 119 | 122 | PF00017 | 0.464 |
LIG_SH2_STAT3 | 30 | 33 | PF00017 | 0.597 |
LIG_SH2_STAT3 | 47 | 50 | PF00017 | 0.576 |
LIG_SH2_STAT5 | 119 | 122 | PF00017 | 0.464 |
LIG_SH2_STAT5 | 160 | 163 | PF00017 | 0.464 |
LIG_SH2_STAT5 | 2 | 5 | PF00017 | 0.647 |
LIG_SH2_STAT5 | 30 | 33 | PF00017 | 0.629 |
LIG_SH2_STAT5 | 67 | 70 | PF00017 | 0.657 |
LIG_SH3_3 | 35 | 41 | PF00018 | 0.609 |
LIG_SH3_3 | 57 | 63 | PF00018 | 0.762 |
LIG_SH3_3 | 65 | 71 | PF00018 | 0.622 |
LIG_SH3_3 | 99 | 105 | PF00018 | 0.576 |
MOD_CK1_1 | 17 | 23 | PF00069 | 0.679 |
MOD_CK1_1 | 197 | 203 | PF00069 | 0.548 |
MOD_CK1_1 | 25 | 31 | PF00069 | 0.651 |
MOD_CK2_1 | 103 | 109 | PF00069 | 0.623 |
MOD_CK2_1 | 71 | 77 | PF00069 | 0.647 |
MOD_Cter_Amidation | 180 | 183 | PF01082 | 0.289 |
MOD_GlcNHglycan | 125 | 128 | PF01048 | 0.318 |
MOD_GlcNHglycan | 165 | 168 | PF01048 | 0.331 |
MOD_GlcNHglycan | 197 | 200 | PF01048 | 0.647 |
MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.661 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.561 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.664 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.656 |
MOD_GSK3_1 | 80 | 87 | PF00069 | 0.695 |
MOD_N-GLC_1 | 17 | 22 | PF02516 | 0.550 |
MOD_N-GLC_1 | 6 | 11 | PF02516 | 0.635 |
MOD_N-GLC_1 | 84 | 89 | PF02516 | 0.681 |
MOD_N-GLC_1 | 96 | 101 | PF02516 | 0.663 |
MOD_NEK2_1 | 84 | 89 | PF00069 | 0.684 |
MOD_PIKK_1 | 17 | 23 | PF00454 | 0.570 |
MOD_PIKK_1 | 58 | 64 | PF00454 | 0.719 |
MOD_PIKK_1 | 7 | 13 | PF00454 | 0.613 |
MOD_PIKK_1 | 96 | 102 | PF00454 | 0.695 |
MOD_PKA_2 | 147 | 153 | PF00069 | 0.505 |
MOD_Plk_1 | 96 | 102 | PF00069 | 0.659 |
MOD_Plk_4 | 128 | 134 | PF00069 | 0.542 |
MOD_Plk_4 | 71 | 77 | PF00069 | 0.703 |
MOD_ProDKin_1 | 28 | 34 | PF00069 | 0.627 |
MOD_ProDKin_1 | 85 | 91 | PF00069 | 0.691 |
TRG_ENDOCYTIC_2 | 156 | 159 | PF00928 | 0.464 |
TRG_Pf-PMV_PEXEL_1 | 143 | 147 | PF00026 | 0.264 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6K2 | Leptomonas seymouri | 80% | 100% |
A0A1X0P9U2 | Trypanosomatidae | 62% | 95% |
A4HHU0 | Leishmania braziliensis | 93% | 100% |
A4I4Y5 | Leishmania infantum | 100% | 100% |
C9ZKJ6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 87% |
E9AEE5 | Leishmania major | 100% | 100% |
E9ALE1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 99% | 100% |